RxDoctor Payments Data

Tina Hughes

Family · Plymouth, MANPI 1528618592

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 2 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Idorsia Pharmaceuticals US Inc accounts for 80.0% of it on its own, with 1 other manufacturer making up the rest. That places this record below the midpoint for family clinicians in MA, where the typical reported total is $157.

$82in general payments, 2019–2025

Across 2 payments — averaging $41.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Idorsia Pharmaceuticals US Inc$66
  • AbbVie$16

What the payments were for

  • Food & beverage$82100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Idorsia Pharmaceuticals US Inc1$66
AbbVie1$16

How this compares

$82 in reported general payments places this provider in the 30th percentile of 2,320 family providers in Massachusetts.

See all family providers in Massachusetts →

Medicare billing

Part B allowed, 2024
$363,867
Medicare patients
246
Services billed
3,004

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban21$11,852
Quetiapine Fumarate405$4,552
Olanzapine234$3,688
Divalproex Sodium152$3,679
Trazodone Hcl283$1,970
Mirtazapine50$1,943
Sertraline Hcl211$1,792
Buspirone Hcl111$1,282
Risperidone99$1,241
Bupropion XlBupropion Hcl21$937
Metoprolol Succinate37$708
Escitalopram Oxalate43$474
Atorvastatin Calcium35$466
Gabapentin68$446
Levothyroxine Sodium39$346

Paid to pharmacies, not to this prescriber.

Other family in Plymouth

See the full list for Massachusetts →

Where these figures come from

Is this you, or does something look wrong? →